A review of tickets was performed for reagent lot number 69367un19, which determined that there was no other complaints related to elevated results.A review of tracking and trending data for the architect magnesium assay identified no trends associated with the complaint issue.Return testing was not completed as returns were not available.Using worldwide field data the performance of reagent lot 69367un19 was evaluated and compared to an established control limit.This evaluation indicated that the patient median result for the reagent lot was within the established control limits.Therefore, no unusual reagent lot performance was identified.Manufacturing documentation including the certificate of analysis for the likely cause lot were reviewed and did not identify any issues associated with the complaint issue.The reagent lot was released within the final release specifications and met all acceptance requirements.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect magnesium assay was identified.
|